Live Updates: COVID-19 Cases
  • World 21,175,952
    World
    Confirmed: 21,175,952
    Active: 6,428,673
    Recovered: 13,987,884
    Death: 759,395
  • USA 5,431,381
    USA
    Confirmed: 5,431,381
    Active: 2,415,103
    Recovered: 2,845,496
    Death: 170,782
  • Brazil 3,229,621
    Brazil
    Confirmed: 3,229,621
    Active: 767,417
    Recovered: 2,356,640
    Death: 105,564
  • India 2,506,247
    India
    Confirmed: 2,506,247
    Active: 686,677
    Recovered: 1,770,682
    Death: 48,888
  • Russia 912,823
    Russia
    Confirmed: 912,823
    Active: 174,361
    Recovered: 722,964
    Death: 15,498
  • South Africa 572,865
    South Africa
    Confirmed: 572,865
    Active: 123,978
    Recovered: 437,617
    Death: 11,270
  • Peru 507,996
    Peru
    Confirmed: 507,996
    Active: 134,342
    Recovered: 348,006
    Death: 25,648
  • Mexico 505,751
    Mexico
    Confirmed: 505,751
    Active: 108,951
    Recovered: 341,507
    Death: 55,293
  • Chile 380,034
    Chile
    Confirmed: 380,034
    Active: 16,604
    Recovered: 353,131
    Death: 10,299
  • Spain 358,843
    Spain
    Confirmed: 358,843
    Active: 330,226
    Recovered: ?
    Death: 28,617
  • Iran 338,825
    Iran
    Confirmed: 338,825
    Active: 25,683
    Recovered: 293,811
    Death: 19,331
  • UK 313,798
    UK
    Confirmed: 313,798
    Active: 272,440
    Recovered: ?
    Death: 41,358
  • Saudi Arabia 295,902
    Saudi Arabia
    Confirmed: 295,902
    Active: 29,605
    Recovered: 262,959
    Death: 3,338
  • Pakistan 287,300
    Pakistan
    Confirmed: 287,300
    Active: 15,932
    Recovered: 265,215
    Death: 6,153
  • Bangladesh 271,881
    Bangladesh
    Confirmed: 271,881
    Active: 111,667
    Recovered: 156,623
    Death: 3,591
  • Italy 252,809
    Italy
    Confirmed: 252,809
    Active: 14,249
    Recovered: 203,326
    Death: 35,234
  • Turkey 245,635
    Turkey
    Confirmed: 245,635
    Active: 11,666
    Recovered: 228,057
    Death: 5,912
  • Germany 222,487
    Germany
    Confirmed: 222,487
    Active: 12,404
    Recovered: 200,800
    Death: 9,283
  • France 209,365
    France
    Confirmed: 209,365
    Active: 95,505
    Recovered: 83,472
    Death: 30,388
  • Canada 121,414
    Canada
    Confirmed: 121,414
    Active: 4,602
    Recovered: 107,793
    Death: 9,019
  • China 84,786
    China
    Confirmed: 84,786
    Active: 690
    Recovered: 79,462
    Death: 4,634
  • Netherlands 61,840
    Netherlands
    Confirmed: 61,840
    Active: 55,673
    Recovered: ?
    Death: 6,167
  • Australia 22,743
    Australia
    Confirmed: 22,743
    Active: 9,018
    Recovered: 13,350
    Death: 375
  • S. Korea 14,873
    S. Korea
    Confirmed: 14,873
    Active: 705
    Recovered: 13,863
    Death: 305
  • New Zealand 1,602
    New Zealand
    Confirmed: 1,602
    Active: 49
    Recovered: 1,531
    Death: 22

ICMR aims to launch indigenous COVID-19 vaccine by Aug 15

Author at TechGenyz Health
Bharat Covaxin
A Photograph of Bharat Covaxin Vaccine.

Aiming to launch an indigenous COVID-19 vaccine by August 15, the Indian Council of Medical Research has written to select medical institutions and hospitals to fast-track clinical trial approvals for the vaccine candidate Covaxin being developed in collaboration with Bharat Biotech.

Twelve clinical trial sites have been identified at present and the apex health research body has asked the medical institutions and principal investigators to ensure that the subject enrolment is initiated no later than July 7.

The COVID-19 vaccine candidate Covaxin, developed by the Hyderabad-based Bharat Biotech in collaboration with the ICMR and the National Institute of Virology (NIV), had recently got the nod for human clinical trials from the DCGI.

Noting that this was the first indigenous vaccine being developed by India, ICMR Director General Dr Balram Bhargava in his letter to principal investigators of the 12 sites said that it is one of the “top priority projects which is being monitored at the top-most level of the government”.

“It is envisaged to launch the vaccine for public health use latest by August 15 after completion of all clinical trials. BBIL is working expeditiously to meet the target, however, final outcome will depend on the cooperation of all clinical trial sites involved in this project.

“You have been chosen as a clinical trial site of the BBV152 COVID vaccine.In view of the public health emergency due to COVID-19 pandemic and urgency to launch the vaccine, you are strictly advised to fast track all approvals related to initiation of the clinical trial and ensure that the subject enrolment is initiated no later than July 7,” Bhargava said in the letter.

The vaccine is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology. Pune- ICMR and BBIL are jointly working for the preclinical as well as clinical development of this vaccine, the letter mentions

The letter warned that any non-compliance will be viewed very seriously.

“Kindly note non-compliance will be viewed very seriously. Therefore, you are advised to treat this project on highest priority and meet the given timelines without any lapse,” the letter stated.

A copy of the letter has been sent to the Bharat Biotech.

India’s COVID-19 cases soared by over 20,000 in a day for the first time taking the country’s total tally to 6,25,544 on Friday while the death toll climbed to 18,213 with 379 new fatalities, according to the Union Health Ministry data.

Career

Subscribe